This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages) This article needs to be updated. Please help update this article to reflect recent events or newly available information. (February 2024) This article contains content that is written like an advertisement. Please help improve it by removing promotional content and inappropriate external links, and by adding encyclopedic content written from a neutral point of view. (June 2024) (Learn how and when to remove this message) (Learn how and when to remove this message)
Icosagen
Company typePrivately held company
IndustryBiotechnology, Biopharmaceutical industry
Founded1999
HeadquartersTartu, Estonia
Key people
Mart Ustav, CEO
ProductsProducts and services in functional genomics and proteomics, latex allergen tests
ServicesCertification: ISO 9001:2000
Websitewww.icosagen.com

Icosagen AS is one of the leading biotechnology companies in Estonia[1] providing medical diagnostics services and performing custom research programs for the biopharmaceutical industry. Formed in 1999 as Quattromed AS, the company has been called Icosagen since 2009.[2]

Profile

[edit]

Quattromed was established in 1999 as a spin-off from Tartu University.[3] It is based in Tartu, Estonia. Employing 80 full-time employees, it has grown into the largest biotechnology company in Estonia. Quattromed started with offering molecular diagnostic services, the activities today cover molecular and clinical diagnostics (Quattromed HTI Laboratories), life science products (Quattromed), latex allergen testing (Quattromed Ltd) and protein production (Quattromed Cell Factory).

Products and services

[edit]

Quattromed’s activities are divided into three branches: medical diagnostics division, technology development division and life science products division. Its main focus of activities is in gene expression and protein production. In-house proprietary technologies are used combined with extensive process know-how and partnership with academic and industrial groups. Quattromed has three patent applications in its IP portfolio, about ten technology licenses and one trade mark.

See also

[edit]

References

[edit]
  1. ^ Frank L. (2001). "Biotechnology in the Baltic". Nature Biotechnology. 19 (6): 513–5. doi:10.1038/89229. PMID 11385442. S2CID 36541802.
  2. ^ "History—Icosagen". Icosagen. Retrieved 2024-06-16.
  3. ^ Estonian Biotechnology Association Archived October 21, 2007, at the Wayback Machine. Retrieved 18. June 2007.
[edit]
Categories